Representative before the EPO

Employment test 11 - 50 employees
Company dna zsp patentanwalte
operating since 1992
Headquarter in Munich and 1 office
active in Legal Services and IP Consulting

Representative before the EPO

Company dna dr volker vossius patent und rechtsanwaltskanzlei
no operation time available
2 offices
active in Legal Services

We have observed 9 EP applications Thomas Wilk has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after September 22, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP15197357

METHODS AND KITS TO DETECT HEREDITARY ANGIOEDEMA TYPE III

IPC classification:
G01N 33/53, A01K 67/027, A61K 48/00, C12Q 1/68
Agent:
Anton Hutter, Venner Shipley LLP
Agent:
Thomas Wilk, Zwicker Schnappauf & Partner Patentanwälte PartG mbB (ZSP)
Status:
APPLICATION PUBLISHED
EP16176546

GENETIC PRODUCTS WHICH ARE DIFFERENTIALLY EXPRESSED IN TUMOURS AND USE THEREOF

IPC classification:
C12Q 1/68, C07K 16/30, C07K 14/47
Applicant:
BioNTech AG
Agent:
Thomas Wilk, Zwicker Schnappauf & Partner Patentanwälte PartG mbB (ZSP)
Status:
APPLICATION PUBLISHED
EP16202946

METHODS AND COMPOSITIONS FOR DIAGNOSIS AND TREATMENT OF CANCER

IPC classification:
A61K 39/395
Applicant:
Ganymed Pharmaceuticals AG
Applicant:
Johannes Gutenberg University Mainz (Johannes Gutenberg-Universität Mainz)
Agent:
Thomas Wilk, Zwicker Schnappauf & Partner Patentanwälte PartG mbB (ZSP)
Status:
APPLICATION PUBLISHED
EP17171169

COMBINATION THERAPY INVOLVING ANTIBODIES AGAINST CLAUDIN 18.2 FOR TREATMENT OF CANCER

IPC classification:
A61K 45/06, C07K 16/30, A61K 39/395
Applicant:
TRON Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg-Universität Mainz gGmbH
Applicant:
Ganymed Pharmaceuticals AG
Agent:
Thomas Wilk, Zwicker Schnappauf & Partner Patentanwälte PartG mbB (ZSP)
Status:
The application has been published
EP17189247

ANTIBODIES SPECIFIC FOR CLAUDIN 6 (CLDN6)

IPC classification:
A61K 39/00, C07K 16/30, A61K 39/395, A61P 35/00, C07K 14/705, C07K 16/28
Applicant:
Johannes Gutenberg University Mainz (Johannes Gutenberg-Universität Mainz)
Applicant:
Ganymed Pharmaceuticals AG
Agent:
Thomas Wilk, Zwicker Schnappauf & Partner Patentanwälte PartG mbB (ZSP)
Status:
The application has been published
EP17201134

MONOCLONAL ANTI-GT468 ANTIBODIES FOR TREATMENT OF CANCER

IPC classification:
A61K 39/395, C07K 16/30
Applicant:
Johannes Gutenberg University Mainz (Johannes Gutenberg-Universität Mainz)
Agent:
Thomas Wilk, Zwicker Schnappauf & Partner Patentanwälte PartG mbB (ZSP)
Status:
The application has been published
EP17192466

MONOCLONAL ANTIBODIES AGAINST CLAUDIN-18 FOR TREATMENT OF CANCER

IPC classification:
A61K 39/00, C07K 16/28, C07K 16/18, A61K 45/06, A61K 51/10, C12N 5/12, A61P 35/00, A61K 39/395, C07K 16/30
Agent:
Thomas Wilk, Zwicker Schnappauf & Partner Patentanwälte PartG mbB (ZSP)
Status:
Request for examination was made
EP18152330

COMPOSITIONS AND METHODS FOR MODIFYING CELL SURFACE GLYCANS

IPC classification:
C12N 9/10, A61K 35/30, A61K 35/28, C12N 5/0735, C12N 5/0775, C12N 5/0797, C12P 1/00, C12N 5/00
Agent:
Thomas Wilk, Zwicker Schnappauf & Partner Patentanwälte PartG mbB (ZSP)
Status:
The application has been published
EP18157559

DIFFERENTIAL IN TUMOUR GENE PRODUCTS AND USE OF SAME

IPC classification:
G01N 33/574, A61K 48/00, C07K 14/47, C12N 5/10, A61P 35/00, A61K 39/395, C12N 15/11, C07K 16/32, C07K 16/30, C07K 16/18
Agent:
Thomas Wilk, Zwicker Schnappauf & Partner Patentanwälte PartG mbB (ZSP)
Status:
The application has been published

Please Sign in to use this feature